Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
161
days
Hematologic changes under [¹⁷⁷Lu]Lu-DOTA-TATE PRRT in GEP-NETs: a long-term longitudinal cohort study
Authors
Christian A. Dascalescu; Felix L. Herr; Ricarda Ebner; Caroline Smith; Victoria Fusch; Matthias P. Fabritius; Mathias J. Zacherl; Florian Eckenweber; Konrad Klimek; Christoph J. Auernhammer; Christine Spitzweg; Maurice M. Heimer; Clemens C. Cyran; Rudolf A. Werner; Gabriel T. SheikhShow moreShow less
Affiliations
1. Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany; 2. Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; 3. Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, GermanyShow moreShow less
307
days
Long-term effects of [ 177 Lu]Lu-PSMA therapy on the kidneys based on cumulative absorbed dose
Authors
Zachary Ells; Muyu Wu; Linus Hempel; Maximilian Scheifele; Sophie C. Siegmund; Julia Ells; Mathias Zacherl; Guido Böning; Jozefina Casuscelli; Rudolf A. Werner; Jeremie Calais; Magnus Dahlbom; Adrien Holzgreve; Astrid Delker; Lena M. UnterrainerShow moreShow less
Affiliations
1. Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; 2. Department of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, University of California Los Angeles UCLA, Los Angeles, USA; 3. Bavarian Cancer Research Center (BZKF), Munich, Germany; 4. Department of Urology, University Hospital Munich, LMU Munich, Munich, Germany; 5. German Cancer Consortium (DKTK), Partner site Munich, a partnership between DKFZ and LMU University Hospital Munich, Munich, GermanyShow moreShow less
195
days
Type of dialysis may influence the prognostic value of myocardial perfusion imaging in end stage renal disease: an observational [ 13 N]NH 3 PET/CT study
Authors
Christian Wenning; Thekla Maria Gosmann; Alexis Vrachimis; Michael A. Schäfers; Stefan ReuterShow moreShow less
Affiliations
1. Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; 2. Department of Nuclear Medicine, Bonifatius Hospital Lingen, Lingen (Ems), Germany; 3. Department of Internal Medicine, Marienhospital Osnabrück, Osnabrück, Germany; 4. Department of Nuclear Medicine, German Medical Center, Limassol, Cyprus; 5. European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany; 6. Department of Internal Medicine D, General Internal Medicine and Nephrology, University Hospital Münster, Münster, GermanyShow moreShow less
214
days
PET pharmacokinetics of [¹⁸F]F-AraG as a marker of T cell activation during immunotherapy with a STING agonist with and without anti-PD-1
Authors
J. E. E. Pouw; M. Stavenga; J. E. Wijngaarden; D. E. Oprea-Lager; P. Schober; R. C. Schuit; S. P. P. van Eeden; A. D. Windhorst; M. M. Murillo; P. Galette; C. A. Parker; T. A. Bonasera; T. D. de Gruijl; M. M. Yaqub; C. W. Menke-van der Houven van Oordt Oordt; R. BoellaardShow moreShow less
Affiliations
1. Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 2. Cancer Centre Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands; 3. GSK, Oncology Imaging, London, UK; 4. Department of Radiology and Nuclear Medicine, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 5. Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands; 6. Department of Anesthesiology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7. GSK, Clinical Imaging, Collegeville, US; 8. Christine Parker – Medical Imaging Consultancy Ltd, Cambridge, UK; 9. Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, NetherlandsShow moreShow less
103
days
Matrix metalloproteinase imaging and survival prospects with aging in murine aortic aneurysm
Authors
Mean Ghim; Onur Varli; Azmi A. Ahmad; Afarin Neishabouri; Gunjan Kukreja; Zhengxing Zhang; Saalar Zarnegar; Nicholas Gangemi; Keshvad Hedayatyanfard; Jakub Toczek; Lingyun Wang; Jiasheng Zhang; Chi Liu; Yongjian Liu; Robert J. Gropler; Mehran M. SadeghiShow moreShow less
Affiliations
1. Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, USA; 2. Veterans Affairs Connecticut Healthcare System, West Haven, USA; 3. Department of Radiology and Biomedical Imaging, Yale University, New Haven, USA; 4. Department of Radiology, Washington University, St. Louis, USAShow moreShow less
220
days
Correlation of apparent diffusion coefficient, FAP expression in IHC and [ 68 Ga]Ga‑FAPI‑46 uptake using integrated PET/MRI in high-grade soft tissue sarcoma: initial exploratory results
Authors
Madelaine Hettler; Franka Menge; Johannes Ludwig; Dominik Nörenberg; Stefan O. Schönberg; Anna Hinterberger; Björn Wängler; Carmen Wängler; Henning Rudolf; Güllü Davarci; Patrick Cieslik; Cristina L. Cotarelo; Melissa Harbrücker; Christoph Reißfelder; Jens Jakob; Wolfgang G. Kunz; Freba GraweShow moreShow less
Affiliations
1. Department of Surgery, Sarcoma Unit, Medical Faculty Mannheim, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany; 2. Department of Surgery, Medical Faculty Mannheim, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany; 3. Department of Radiology and Nuclear Medicine, Medical Faculty Mannheim, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany; 4. DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Heidelberg, Germany; 5. Medical Faculty Mannheim, Clinic of Radiology and Nuclear Medicine, Molecular Imaging and Radiochemistry, Heidelberg University, Mannheim, Germany; 6. Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 7. Mannheim Institute for Intelligent Systems in Medicine (MIISM), Mannheim, Germany; 8. Medical Faculty Mannheim, Clinic of Radiology and Nuclear Medicine, Biomedical Chemistry, Heidelberg University, Mannheim, Germany; 9. Institute of Pathology, Medical Faculty Mannheim, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany; 10. Department of Radiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, GermanyShow moreShow less
FAQ
How long does EJNMMI Research take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for EJNMMI Research. The fastest paper went from submission to acceptance in 41 days (Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [ 11 C]AZ14193391, received 2026-05-21, accepted 2026-07-01); the slowest took 307 days. The average is 154.1 days and the median is 146.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
